The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration

Ophthalmology

Volumn 121, Issue 6, 2014, Pages 1246-1251

  Finger, Robert P ^a   Guymer, Robyn H ^a   Gillies, Mark C ^b   Keeffe, Jill E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Abbreviations and Acronyms; age related macular degeneration; AMD; distance visual acuity; DVA; Impact of Vision Impairment; IVI; National Eye Institute Visual Functioning Questionnaire 25 items; NEI VFQ 25; OCT; optical coherence tomography; QoL; quality of life; SD; standard deviation; VA; vascular endothelial growth factor; VEGF; vision related quality of life; visual acuity; VRQoL

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN INHIBITOR;

AGED; ARTICLE; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; IMPACT OF VISION IMPAIRMENT QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; RETINAL THICKNESS; VISION; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISION, OCULAR; VISUAL ACUITY; VISUALLY IMPAIRED PERSONS; WET MACULAR DEGENERATION;

EID: 84901760647     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.12.032     Document Type: Article

References (26)

1. L.S. Lim, P. Mitchell, and J.M. Seddon et al. Age-related macular degeneration Lancet 379 2012 1728 1738
2. G. Querques, S. Azrya, and D. Martinelli et al. Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting Br J Ophthalmol 94 2010 292 296
3. L. Hjelmqvist, C. Lindberg, and P. Kanulf et al. One-year outcomes using ranibizumab for neovascular age-related macular degeneration: results of a prospective and retrospective observational multicentre study J Ophthalmol 2011 2011 405724
4. B. Heimes, A. Lommatzsch, and M. Zeimer et al. Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme Graefes Arch Clin Exp Ophthalmol 249 2011 639 644
5. R.P. Finger, E. Fenwick, and M. Marella et al. The impact of vision impairment on vision-specific quality of life in Germany Invest Ophthalmol Vis Sci 52 2011 3613 3619
6. T.S. Chang, N.M. Bressler, and J.T. Fine et al. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial Arch Ophthalmol 125 2007 1460 1469 (Pubitemid 350106676)
7. N.M. Bressler, T.S. Chang, and I.J. Suner et al. Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR Ophthalmology 117 2010 747 e4 756 e4
8. R.P. Finger, P. Wiedemann, F. Blumhagen, K. Pohl, and F.G. Holz Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany Acta Ophthalmol 91 2013 540 546
9. R.P. Finger, A.E. Hoffmann, and E.K. Fenwick et al. Patients' preferences in treatment for neovascular age-related macular degeneration in clinical routine Br J Ophthalmol 96 2012 997 1002
10. M. Marella, K. Pesudovs, and J.E. Keeffe et al. The psychometric validity of the NEI VFQ-25 for use in a low-vision population Invest Ophthalmol Vis Sci 51 2010 2878 2884
11. L.M. Weih, J.B. Hassell, and J.E. Keeffe Assessment of the impact of vision impairment Invest Ophthalmol Vis Sci 43 2002 927 935 (Pubitemid 34258257)
12. E.L. Lamoureux, J.F. Pallant, and K. Pesudovs et al. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and Rasch analysis Invest Ophthalmol Vis Sci 48 2007 1001 1006 (Pubitemid 351261389)
13. E.L. Lamoureux, J.B. Hassell, and J.E. Keeffe The determinants of participation in activities of daily living in people with impaired vision Am J Ophthalmol 137 2004 265 270 (Pubitemid 38220998)
14. E.L. Lamoureux, J.F. Pallant, and K. Pesudovs et al. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis Invest Ophthalmol Vis Sci 47 2006 4732 4741 (Pubitemid 46586369)
15. E. Garamendi, K. Pesudovs, M.J. Stevens, and D.B. Elliott The Refractive Status and Vision Profile: Evaluation of psychometric properties and comparison of Rasch and summated Likert-scaling Vision Res 46 2006 1375 1383 (Pubitemid 43075312)
16. J.M. Norquist, R. Fitzpatrick, J. Dawson, and C. Jenkinson Comparing alternative Rasch-based methods vs raw scores in measuring change in health Med Care 42 1 Suppl 2004 I25 I36
17. K. Pesudovs Patient-centered measurement in ophthalmology - a paradigm shift BMC Ophthalmol 6 2006 25
18. K. Pesudovs Autorefraction as an outcome measure of laser in situ keratomileusis J Cataract Refract Surg 30 2004 1921 1928 (Pubitemid 39165923)
19. E. Lamoureux, and K. Pesudovs Vision-specific quality-of-life research: a need to improve the quality Am J Ophthalmol 151 2011 195 e2 197 e2
20. R.P. Finger, E. Fenwick, and K. Pesudovs et al. Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire Ophthalmology 119 2012 2351 2357
21. K. Pesudovs, J.M. Burr, C. Harley, and D.B. Elliott The development, assessment, and selection of questionnaires Optom Vis Sci 84 2007 663 674 (Pubitemid 47262976)
22. B.D. Wright Rack and stack: time 1 vs. time 2 or pre-test vs. post-test Rasch Measurement Transactions 17 2003 905 906
23. T.W. Chien Repeated measure designs (time series) and Rasch Rasch Measurement Transactions 22 2008 1171
24. A. Arditi, and R. Cagenello On the statistical reliability of letter-chart visual acuity measurements Invest Ophthalmol Vis Sci 34 1993 120 129 (Pubitemid 23045109)
25. A.K. Kiser, D. Mladenovich, and F. Eshraghi et al. Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease Optom Vis Sci 82 2005 946 954 (Pubitemid 41778759)
26. S.P. Rothenbuehler, D. Waeber, and C.K. Brinkmann et al. Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration Am J Ophthalmol 147 2009 831 837